Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics
Open Access
- 15 September 2001
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 98 (6), 1963-1970
- https://doi.org/10.1182/blood.v98.6.1963
Abstract
In this study, mononuclear cells (MNCs) from granulocyte colony-stimulating factor (G-CSF)–mobilized blood stem cell (BSC) harvests from 104 healthy donors were analyzed for their immunological functions and compared with MNCs from 28 steady-state nonmobilized donors. The relationships between donor characteristics (age, gender, weight, and HLA type) and immune functions of the harvests were also analyzed. There was a significant (P < .01) decrease in natural killer and lymphokine-activated killer (LAK) cell–mediated cytotoxicity for G-CSF–mobilized effector cells compared with nonmobilized cells. Similarly, there was a significant (P < .005) decrease in both T-cell and B-cell mitogen response in G-CSF–mobilized cells compared with nonmobilized cells. There was dose-dependent inhibition of LAK cell–mediated cytotoxicity, but this effect was not seen with other immune function assays. Changes in immune function did not appear to be determined by frequency of cellular phenotypes or expression of effector function genes seen in a reverse-transcription polymerase chain reaction. There was a significant relationship between expression of certain HLA alleles (A1, A3, A24, B44, B62, DR15, DR17; allP < .01) and increased immune function, such as cytotoxicity and/or mitogen response. A decrease in immune function with the HLA-DR13 expression was also observed (P < .01). Since the G-CSF increases the number of MNCs, the increase in effector cells might compensate for decreased immune functions of these cells in vivo when transplanted into patients. These results suggest a decreased immune function in G-CSF–mobilized BSC harvests and warrant further studies to correlate these data with clinical outcome.Keywords
This publication has 22 references indexed in Scilit:
- G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte functionBone Marrow Transplantation, 2000
- Administration of G-CSF to normal individuals diminishes L-selectin+ T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin− T cellsBone Marrow Transplantation, 1999
- Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC productsBone Marrow Transplantation, 1998
- Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsBone Marrow Transplantation, 1998
- Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignanciesBone Marrow Transplantation, 1998
- Effect of the in vivo priming regimen for peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a murine modelBone Marrow Transplantation, 1997
- Transplantation of peripheral blood progenitor cells from HLA‐identical sibling donorsBritish Journal of Haematology, 1996
- Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony Stimulating FactorThe International Journal of Cell Cloning, 1996
- Interleukin-2 therapy of lymphoma-bearing immunosuppressed miceClinical & Experimental Metastasis, 1994
- Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: role of granulocyte colony-stimulating factorImmunology Letters, 1993